ONTOLOGY REPORT - ANNOTATIONS
| Term: | simazine |
|
| Accession: | CHEBI:27496
|
browse the term
|
| Definition: | A chloro-1,3,5-triazine herbicide that has formula C7H12ClN5. |
| Synonyms: | related_synonym: | 2-chloro-4,6-bis(ethylamino)-1,3,5-triazine; 2-chloro-4,6-bis(ethylamino)-s-triazine; 6-chloro-N(2),N(4)-diethyl-1,3,5-triazine-2,4-diamine; 6-chloro-N,N'-diethyl-[1,3,5]triazin-2,4-diamine; C7H12ClN5; CCNc1nc(Cl)nc(NCC)n1; Gesatop; InChI=1S/C7H12ClN5/c1-3-9-6-11-5(8)12-7(13-6)10-4-2/h3-4H2,1-2H3,(H2,9,10,11,12,13); InChIKey=ODCWYMIRDDJXKW-UHFFFAOYSA-N; Princep; Simanex |
| | alt_id: | CHEBI:26679; CHEBI:9146 |
| | xref_casrn: | 122-34-9 |
| | xref: | Beilstein:10895 "Beilstein Registry Number"; ChEMBL:1129721 "ChEMBL COMPOUND"; ChemIDplus:122-34-9 "CAS Registry Number"; KEGG COMPOUND:122-34-9 "CAS Registry Number"; KEGG COMPOUND:C11172 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D012839 |
| | xref: | NIST Chemistry WebBook:122-34-9 "CAS Registry Number"; UM-BBD:c0254 "UM-BBD compID" |
|
|
simazine
|
| G |
Creb5 |
cAMP responsive element binding protein 5 |
|
decreases expression |
ISO |
4 |
81,719,509 |
82,033,894 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases metabolic processing |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases activity |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases activity |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
increases expression |
EXP |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
increases activity |
EXP |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
multiple interactions |
EXP |
3 |
6,052,706 |
6,069,826 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
decreases expression |
EXP |
3 |
6,052,706 |
6,069,826 |
RGD:6480464 |
CTD |
| G |
Dtwd2 |
DTW domain containing 2 |
|
increases expression |
ISO |
18 |
44,628,808 |
44,718,486 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Ifnb1 |
interferon beta 1, fibroblast |
|
multiple interactions |
ISO |
5 |
107,837,628 |
107,838,182 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mos |
Moloney sarcoma oncogene |
|
increases expression |
ISO |
5 |
17,158,906 |
17,160,204 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
|
increases expression |
ISO |
3 |
18,498,913 |
18,519,738 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
decreases expression |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Pde4a |
phosphodiesterase 4A, cAMP-specific |
|
decreases activity |
ISO |
8 |
20,192,677 |
20,241,557 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Plcz1 |
phospholipase C, zeta 1 |
|
increases expression |
ISO |
4 |
177,096,157 |
177,162,109 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases secretion |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Rxfp1 |
relaxin/insulin-like family peptide receptor 1 |
|
decreases expression |
ISO |
2 |
171,044,633 |
171,163,195 |
RGD:6480464 |
CTD |
| G |
Scgb2a2 |
secretoglobin, family 2A, member 2 |
|
decreases expression |
EXP |
1 |
212,162,326 |
212,165,105 |
RGD:6480464 |
CTD |
| G |
Spag6 |
sperm associated antigen 6 |
|
decreases expression |
ISO |
11 |
86,208,991 |
86,321,358 |
RGD:6480464 |
CTD |
| G |
Tas2r129 |
taste receptor, type 2, member 129 |
|
decreases expression |
ISO |
4 |
170,088,591 |
170,089,553 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tssk1b |
testis-specific serine kinase 1B |
|
decreases expression |
ISO |
11 |
85,079,063 |
85,080,486 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
Term paths to the root
| Path 1 |
CHEBI ontology |
492574 |
 |
role |
482262 |
 |
application |
245197 |
 |
pesticide |
64511 |
 |
| herbicide |
3349 |
 |
1,3,5-triazine herbicide |
395 |
 |
chloro-1,3,5-triazine herbicide |
386 |
 |
simazine |
41 |
 |
| Path 2 |
CHEBI ontology |
492574 |
 |
subatomic particle |
491537 |
 |
composite particle |
491537 |
 |
hadron |
491537 |
 |
baryon |
491537 |
 |
nucleon |
491537 |
 |
atomic nucleus |
491537 |
 |
atom |
491537 |
 |
main group element atom |
461203 |
 |
p-block element atom |
458699 |
 |
carbon group element atom |
410677 |
 |
carbon atom |
407233 |
 |
organic molecular entity |
407226 |
 |
organic molecule |
359465 |
 |
organic cyclic compound |
298342 |
 |
organic heterocyclic compound |
154273 |
 |
heteroarene |
29373 |
 |
azaarene |
1782 |
 |
triazines |
834 |
 |
1,3,5-triazines |
802 |
 |
diamino-1,3,5-triazine |
400 |
 |
| 1,3,5-triazine-2,4-diamine |
391 |
 |
| 6-chloro-1,3,5-triazine-2,4-diamine |
391 |
 |
chloro-1,3,5-triazine herbicide |
386 |
 |
simazine |
41 |
 |
| |
|